Micobiomed Overview

  • Founded
  • 2009
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 4

Micobiomed General Information


Developer of medical reagents intended to diagnose infectious agents. The company's reagents blend molecular technology, biochemistry diagnosis and immunodiahnostics technology that accurately diagnose infectious agents, enabling healthcare industry to get an optimized system for preemptive responses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Monitoring Equipment
Primary Office
  • 815, Daewangpangyo-ro
  • Sujeong-gu
  • Seongnam-si, Gyeonggi-do
  • South Korea
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Micobiomed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC Completed Startup
2. Accelerator/Incubator Completed Startup
1. Joint Venture 01-Jul-2009 Completed Startup

Micobiomed Executive Team (2)

Name Title Board Seat Contact Info
Kang Byung Seung Chief Executive Officer

1 Former Executive

Micobiomed Investors (4)

To view Micobiomed‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Korea Research Institute of Bioscience and Biotechnology Other Majority 000 0000 000000 0
MiCo(Korea) Other Majority 000 0000 000000 0
KIC Europe Accelerator/Incubator Minority 000 0000 000000 0
Seoul Investment Partners Venture Capital Minority 000 0000 000000 0

Micobiomed Acquisitions (1)

To view Micobiomed‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 00000000000 24-May-2018 000000000000000000 00.00 Diagnostic Equipment

Ready to get started?

Request a free trial